Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Drug Recalls Topic Center

The Latest

News
05/02/2024
Jolynn Tumolo
Cipla USA Inc. is recalling two lots of ipratropium bromide and albuterol sulfate inhalation solution.
Cipla USA Inc. is recalling two lots of ipratropium bromide and albuterol sulfate inhalation solution.
Cipla USA Inc. is recalling two...
05/02/2024
Pharmacy Learning Network
News
05/02/2024
Jolynn Tumolo
Nomax Inc. is recalling more than 42,000 cartons of GloStrips and Ful-Glo fluorescein sodium ophthalmic strips because the active pharmaceutical ingredient used in the products failed to meet impurity specifications.
Nomax Inc. is recalling more than 42,000 cartons of GloStrips and Ful-Glo fluorescein sodium ophthalmic strips because the active pharmaceutical ingredient used in the products failed to meet impurity specifications.
Nomax Inc. is recalling more...
05/02/2024
Pharmacy Learning Network
News
05/01/2024
Jolynn Tumolo
More than 40 lots of Aruba Aloe Hand Sanitizer Gel and Aruba Aloe Alcoholada Gel are under a Class I recall because they have been found to contain alcohol denatured with methanol.
More than 40 lots of Aruba Aloe Hand Sanitizer Gel and Aruba Aloe Alcoholada Gel are under a Class I recall because they have been found to contain alcohol denatured with methanol.
More than 40 lots of Aruba Aloe...
05/01/2024
Pharmacy Learning Network
News
04/24/2024
Jolynn Tumolo
Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Lupin Pharmaceuticals Inc. is...
04/24/2024
Pharmacy Learning Network
News
04/24/2024
Jolynn Tumolo
Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...
Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...
Teva Pharmaceuticals USA Inc. is...
04/24/2024
Pharmacy Learning Network
News
04/18/2024
Jolynn Tumolo
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter...
04/18/2024
Pharmacy Learning Network
News
04/17/2024
Jolynn Tumolo
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and...
04/17/2024
Pharmacy Learning Network
News
04/16/2024
Jolynn Tumolo
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is...
04/16/2024
Pharmacy Learning Network
News
04/09/2024
Jolynn Tumolo
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling...
04/09/2024
Pharmacy Learning Network
News
04/05/2024
Jolynn Tumolo
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is...
04/05/2024
Pharmacy Learning Network
News
04/04/2024
Jolynn Tumolo
Apothecus Pharmaceutical Corp. is recalling 17,280 cartons of VCF Vaginal Contraceptive Film. According to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, deviations from Current Good Manufacturing Practice...
Apothecus Pharmaceutical Corp. is recalling 17,280 cartons of VCF Vaginal Contraceptive Film. According to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, deviations from Current Good Manufacturing Practice...
Apothecus Pharmaceutical Corp....
04/04/2024
Pharmacy Learning Network

Newsfeed

News
05/02/2024
Jolynn Tumolo
Cipla USA Inc. is recalling two lots of ipratropium bromide and albuterol sulfate inhalation solution.
Cipla USA Inc. is recalling two lots of ipratropium bromide and albuterol sulfate inhalation solution.
Cipla USA Inc. is recalling two...
05/02/2024
Pharmacy Learning Network
News
05/02/2024
Jolynn Tumolo
Nomax Inc. is recalling more than 42,000 cartons of GloStrips and Ful-Glo fluorescein sodium ophthalmic strips because the active pharmaceutical ingredient used in the products failed to meet impurity specifications.
Nomax Inc. is recalling more than 42,000 cartons of GloStrips and Ful-Glo fluorescein sodium ophthalmic strips because the active pharmaceutical ingredient used in the products failed to meet impurity specifications.
Nomax Inc. is recalling more...
05/02/2024
Pharmacy Learning Network
News
05/01/2024
Jolynn Tumolo
More than 40 lots of Aruba Aloe Hand Sanitizer Gel and Aruba Aloe Alcoholada Gel are under a Class I recall because they have been found to contain alcohol denatured with methanol.
More than 40 lots of Aruba Aloe Hand Sanitizer Gel and Aruba Aloe Alcoholada Gel are under a Class I recall because they have been found to contain alcohol denatured with methanol.
More than 40 lots of Aruba Aloe...
05/01/2024
Pharmacy Learning Network
News
04/24/2024
Jolynn Tumolo
Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Lupin Pharmaceuticals Inc. is...
04/24/2024
Pharmacy Learning Network
News
04/24/2024
Jolynn Tumolo
Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...
Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...
Teva Pharmaceuticals USA Inc. is...
04/24/2024
Pharmacy Learning Network
News
04/18/2024
Jolynn Tumolo
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter...
04/18/2024
Pharmacy Learning Network
News
04/17/2024
Jolynn Tumolo
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and...
04/17/2024
Pharmacy Learning Network
News
04/16/2024
Jolynn Tumolo
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is...
04/16/2024
Pharmacy Learning Network
News
04/09/2024
Jolynn Tumolo
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling...
04/09/2024
Pharmacy Learning Network
News
04/05/2024
Jolynn Tumolo
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was...
Par Sterile Products is...
04/05/2024
Pharmacy Learning Network
News
05/02/2024
Jolynn Tumolo
Cipla USA Inc. is recalling two lots of ipratropium bromide and albuterol sulfate inhalation solution.
Cipla USA Inc. is recalling two lots of ipratropium bromide and albuterol sulfate inhalation solution.
Cipla USA Inc. is recalling two...
05/02/2024
Pharmacy Learning Network
News
05/02/2024
Jolynn Tumolo
Nomax Inc. is recalling more than 42,000 cartons of GloStrips and Ful-Glo fluorescein sodium ophthalmic strips because the active pharmaceutical ingredient used in the products failed to meet impurity specifications.
Nomax Inc. is recalling more than 42,000 cartons of GloStrips and Ful-Glo fluorescein sodium ophthalmic strips because the active pharmaceutical ingredient used in the products failed to meet impurity specifications.
Nomax Inc. is recalling more...
05/02/2024
Pharmacy Learning Network
News
05/01/2024
Jolynn Tumolo
More than 40 lots of Aruba Aloe Hand Sanitizer Gel and Aruba Aloe Alcoholada Gel are under a Class I recall because they have been found to contain alcohol denatured with methanol.
More than 40 lots of Aruba Aloe Hand Sanitizer Gel and Aruba Aloe Alcoholada Gel are under a Class I recall because they have been found to contain alcohol denatured with methanol.
More than 40 lots of Aruba Aloe...
05/01/2024
Pharmacy Learning Network
News
04/26/2024
Hannah Musick
The FDA proposed introducing a Patient Medication Information (PMI), in addition to the Medication Guide, to provide clear and concise details about prescription medications to improve patient understanding and adherence, ultimately reducing...
The FDA proposed introducing a Patient Medication Information (PMI), in addition to the Medication Guide, to provide clear and concise details about prescription medications to improve patient understanding and adherence, ultimately reducing...
The FDA proposed introducing a...
04/26/2024
Pharmacy Learning Network
News
04/24/2024
Jolynn Tumolo
Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Lupin Pharmaceuticals Inc. is...
04/24/2024
Pharmacy Learning Network
News
04/24/2024
Jolynn Tumolo
Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...
Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...
Teva Pharmaceuticals USA Inc. is...
04/24/2024
Pharmacy Learning Network
News
04/18/2024
Jolynn Tumolo
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter...
04/18/2024
Pharmacy Learning Network
News
04/17/2024
Jolynn Tumolo
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and...
04/17/2024
Pharmacy Learning Network
News
04/16/2024
Danielle Sposato
On Tuesday, April 16, the FDA alerted consumers and health care professionals alike to widely distributed counterfeit versions of Botox that were administered to consumers across Colorado, Nebraska, Illinois, Florida, Kentucky, New York,...
On Tuesday, April 16, the FDA alerted consumers and health care professionals alike to widely distributed counterfeit versions of Botox that were administered to consumers across Colorado, Nebraska, Illinois, Florida, Kentucky, New York,...
On Tuesday, April 16, the FDA...
04/16/2024
Pharmacy Learning Network
News
04/16/2024
Jolynn Tumolo
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is...
04/16/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement